annual operating profit:
$218.08M+$485.90M(+181.43%)Summary
- As of today (May 24, 2025), SRPT annual operating income is $218.08 million, with the most recent change of +$485.90 million (+181.43%) on December 31, 2024.
- During the last 3 years, SRPT annual operating profit has risen by +$667.79 million (+148.49%).
- SRPT annual operating profit is now at all-time high.
Performance
SRPT Operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating profit:
-$300.39M-$462.07M(-285.79%)Summary
- As of today (May 24, 2025), SRPT quarterly operating income is -$300.39 million, with the most recent change of -$462.07 million (-285.79%) on March 1, 2025.
- Over the past year, SRPT quarterly operating profit has dropped by -$335.29 million (-960.58%).
- SRPT quarterly operating profit is now -285.79% below its all-time high of $161.68 million, reached on December 31, 2024.
Performance
SRPT quarterly operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM operating profit:
-$117.21M-$335.29M(-153.75%)Summary
- As of today (May 24, 2025), SRPT TTM operating income is -$117.21 million, with the most recent change of -$335.29 million (-153.75%) on March 1, 2025.
- Over the past year, SRPT TTM operating profit has dropped by -$22.38 million (-23.60%).
- SRPT TTM operating profit is now -153.75% below its all-time high of $218.08 million, reached on December 31, 2024.
Performance
SRPT TTM operating profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating profit Formula
Operating Profit = Gross Profit − Operating Expenses
SRPT Operating profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +181.4% | -960.6% | -23.6% |
| 3 y3 years | +148.5% | -245.7% | +70.3% |
| 5 y5 years | +141.8% | -154.5% | +79.2% |
SRPT Operating profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +140.7% | -285.8% | at low | -153.8% | +80.0% |
| 5 y | 5-year | at high | +138.7% | -285.8% | at low | -153.8% | +81.0% |
| alltime | all time | at high | +138.7% | -285.8% | at low | -153.8% | +81.0% |
SRPT Operating profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2025 | - | -$300.39M(-285.8%) | -$117.21M(-153.7%) |
| Dec 2024 | $218.08M(-181.4%) | $161.68M(+628.4%) | $218.08M(+169.2%) |
| Sep 2024 | - | $22.20M(-3266.3%) | $81.03M(+113.3%) |
| Jun 2024 | - | -$701.00K(-102.0%) | $37.99M(-140.1%) |
| Mar 2024 | - | $34.91M(+41.7%) | -$94.83M(-64.6%) |
| Dec 2023 | -$267.82M(-50.1%) | $24.63M(-218.2%) | -$267.82M(-32.9%) |
| Sep 2023 | - | -$20.84M(-84.4%) | -$399.28M(-21.7%) |
| Jun 2023 | - | -$133.52M(-3.3%) | -$509.80M(-13.2%) |
| Mar 2023 | - | -$138.09M(+29.3%) | -$587.41M(+9.5%) |
| Dec 2022 | -$536.20M(+19.2%) | -$106.83M(-18.7%) | -$536.20M(+0.2%) |
| Sep 2022 | - | -$131.35M(-37.8%) | -$535.18M(+22.1%) |
| Jun 2022 | - | -$211.13M(+143.0%) | -$438.28M(+11.0%) |
| Mar 2022 | - | -$86.88M(-17.9%) | -$394.73M(-12.2%) |
| Dec 2021 | -$449.71M(-20.3%) | -$105.81M(+207.1%) | -$449.71M(-12.6%) |
| Sep 2021 | - | -$34.46M(-79.4%) | -$514.61M(-16.6%) |
| Jun 2021 | - | -$167.57M(+18.1%) | -$617.22M(+5.0%) |
| Mar 2021 | - | -$141.87M(-16.9%) | -$588.00M(+4.2%) |
| Dec 2020 | -$564.16M(+8.0%) | -$170.72M(+24.5%) | -$564.16M(-8.1%) |
| Sep 2020 | - | -$137.07M(-0.9%) | -$613.67M(+2.2%) |
| Jun 2020 | - | -$138.35M(+17.2%) | -$600.19M(+6.4%) |
| Mar 2020 | - | -$118.03M(-46.4%) | -$563.96M(+8.0%) |
| Dec 2019 | -$522.32M(+52.0%) | -$220.22M(+78.2%) | -$522.32M(+18.9%) |
| Sep 2019 | - | -$123.59M(+21.0%) | -$439.25M(+13.9%) |
| Jun 2019 | - | -$102.13M(+33.7%) | -$385.75M(-0.9%) |
| Mar 2019 | - | -$76.39M(-44.3%) | -$389.28M(+13.3%) |
| Dec 2018 | -$343.63M(+139.9%) | -$137.14M(+95.6%) | -$343.63M(+48.0%) |
| Sep 2018 | - | -$70.10M(-33.6%) | -$232.22M(+27.3%) |
| Jun 2018 | - | -$105.65M(+243.7%) | -$182.44M(+35.3%) |
| Mar 2018 | - | -$30.74M(+19.4%) | -$134.87M(-5.9%) |
| Dec 2017 | -$143.21M(-45.8%) | -$25.74M(+26.7%) | -$143.38M(-29.8%) |
| Sep 2017 | - | -$20.32M(-65.0%) | -$204.13M(-15.1%) |
| Jun 2017 | - | -$58.08M(+48.0%) | -$240.34M(-1.6%) |
| Mar 2017 | - | -$39.24M(-54.6%) | -$244.25M(-7.7%) |
| Dec 2016 | -$264.18M(+20.0%) | -$86.49M(+53.0%) | -$264.71M(+9.1%) |
| Sep 2016 | - | -$56.53M(-8.8%) | -$242.67M(+2.0%) |
| Jun 2016 | - | -$61.98M(+3.8%) | -$237.90M(+9.1%) |
| Mar 2016 | - | -$59.70M(-7.4%) | -$218.02M(-1.0%) |
| Dec 2015 | -$220.18M(+64.6%) | -$64.45M(+24.5%) | -$220.18M(+9.8%) |
| Sep 2015 | - | -$51.76M(+22.9%) | -$200.45M(+9.9%) |
| Jun 2015 | - | -$42.11M(-31.9%) | -$182.37M(+6.9%) |
| Mar 2015 | - | -$61.86M(+38.3%) | -$170.53M(+27.5%) |
| Dec 2014 | -$133.79M(+48.2%) | -$44.72M(+32.8%) | -$133.79M(+9.7%) |
| Sep 2014 | - | -$33.67M(+11.2%) | -$121.92M(+7.7%) |
| Jun 2014 | - | -$30.27M(+20.5%) | -$113.17M(+13.2%) |
| Mar 2014 | - | -$25.12M(-23.5%) | -$99.99M(+10.8%) |
| Dec 2013 | -$90.28M(+204.0%) | -$32.85M(+31.7%) | -$90.28M(+33.2%) |
| Sep 2013 | - | -$24.93M(+45.9%) | -$67.80M(+36.2%) |
| Jun 2013 | - | -$17.09M(+10.8%) | -$49.77M(+30.1%) |
| Mar 2013 | - | -$15.41M(+48.7%) | -$38.24M(+28.8%) |
| Dec 2012 | -$29.70M(-17.3%) | -$10.37M(+50.1%) | -$29.70M(+4.8%) |
| Sep 2012 | - | -$6.91M(+24.3%) | -$28.34M(-13.4%) |
| Jun 2012 | - | -$5.56M(-19.2%) | -$32.70M(-12.3%) |
| Mar 2012 | - | -$6.87M(-23.6%) | -$37.27M(+3.7%) |
| Dec 2011 | -$35.93M(+71.6%) | -$9.00M(-20.1%) | -$35.93M(+25.3%) |
| Sep 2011 | - | -$11.27M(+11.3%) | -$28.67M(+35.3%) |
| Jun 2011 | - | -$10.13M(+83.1%) | -$21.19M(+13.1%) |
| Mar 2011 | - | -$5.53M(+217.9%) | -$18.73M(-10.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2010 | -$20.93M(+35.0%) | -$1.74M(-54.2%) | -$20.94M(-9.6%) |
| Sep 2010 | - | -$3.80M(-50.5%) | -$23.16M(+3.9%) |
| Jun 2010 | - | -$7.67M(-0.9%) | -$22.28M(+13.2%) |
| Mar 2010 | - | -$7.74M(+95.4%) | -$19.68M(+26.9%) |
| Dec 2009 | -$15.51M(-11.6%) | -$3.96M(+35.6%) | -$15.51M(+7.4%) |
| Sep 2009 | - | -$2.92M(-42.3%) | -$14.44M(-17.3%) |
| Jun 2009 | - | -$5.07M(+42.1%) | -$17.46M(+1.1%) |
| Mar 2009 | - | -$3.56M(+23.2%) | -$17.28M(-1.5%) |
| Dec 2008 | -$17.54M(-47.0%) | -$2.89M(-51.3%) | -$17.54M(-13.7%) |
| Sep 2008 | - | -$5.94M(+21.7%) | -$20.32M(-11.3%) |
| Jun 2008 | - | -$4.88M(+27.4%) | -$22.89M(-14.8%) |
| Mar 2008 | - | -$3.83M(-32.4%) | -$26.85M(-18.9%) |
| Dec 2007 | -$33.11M(+0.4%) | -$5.67M(-33.4%) | -$33.11M(-8.6%) |
| Sep 2007 | - | -$8.51M(-3.7%) | -$36.21M(+3.5%) |
| Jun 2007 | - | -$8.84M(-12.3%) | -$34.97M(+4.2%) |
| Mar 2007 | - | -$10.09M(+15.0%) | -$33.55M(+1.7%) |
| Dec 2006 | -$32.98M(+88.3%) | -$8.77M(+20.6%) | -$32.98M(+13.3%) |
| Sep 2006 | - | -$7.27M(-2.0%) | -$29.12M(+22.5%) |
| Jun 2006 | - | -$7.42M(-22.1%) | -$23.76M(+10.6%) |
| Mar 2006 | - | -$9.52M(+94.1%) | -$21.49M(+22.7%) |
| Dec 2005 | -$17.52M(-30.1%) | -$4.91M(+155.8%) | -$17.52M(-0.2%) |
| Sep 2005 | - | -$1.92M(-62.8%) | -$17.55M(-15.4%) |
| Jun 2005 | - | -$5.15M(-7.2%) | -$20.75M(-9.1%) |
| Mar 2005 | - | -$5.55M(+12.3%) | -$22.84M(-8.8%) |
| Dec 2004 | -$25.04M(+32.7%) | -$4.94M(-3.6%) | -$25.04M(-8.1%) |
| Sep 2004 | - | -$5.12M(-29.2%) | -$27.27M(+1.7%) |
| Jun 2004 | - | -$7.23M(-6.7%) | -$26.82M(+15.9%) |
| Mar 2004 | - | -$7.75M(+8.3%) | -$23.14M(+22.6%) |
| Dec 2003 | -$18.87M(-25.5%) | -$7.16M(+53.0%) | -$18.87M(+18.9%) |
| Sep 2003 | - | -$4.68M(+31.7%) | -$15.87M(-4.2%) |
| Jun 2003 | - | -$3.55M(+2.1%) | -$16.56M(-20.9%) |
| Mar 2003 | - | -$3.48M(-16.1%) | -$20.93M(-17.4%) |
| Dec 2002 | -$25.34M(+64.5%) | -$4.15M(-22.7%) | -$25.34M(-2.2%) |
| Sep 2002 | - | -$5.37M(-32.2%) | -$25.92M(+8.5%) |
| Jun 2002 | - | -$7.92M(+0.3%) | -$23.89M(+20.9%) |
| Mar 2002 | - | -$7.90M(+66.9%) | -$19.76M(+28.3%) |
| Dec 2001 | -$15.40M(+50.4%) | -$4.73M(+41.5%) | -$15.40M(+9.1%) |
| Sep 2001 | - | -$3.35M(-11.6%) | -$14.12M(+5.6%) |
| Jun 2001 | - | -$3.78M(+6.9%) | -$13.37M(+6.6%) |
| Mar 2001 | - | -$3.54M(+2.5%) | -$12.54M(+22.5%) |
| Dec 2000 | -$10.24M(+23.4%) | -$3.45M(+33.3%) | -$10.24M(+12.7%) |
| Sep 2000 | - | -$2.59M(-12.3%) | -$9.09M(+4.5%) |
| Jun 2000 | - | -$2.96M(+138.2%) | -$8.70M(+13.8%) |
| Mar 2000 | - | -$1.24M(-46.1%) | -$7.64M(-4.5%) |
| Dec 1999 | -$8.30M(+6.4%) | -$2.30M(+4.5%) | -$8.00M(-3.6%) |
| Sep 1999 | - | -$2.20M(+15.8%) | -$8.30M(+5.1%) |
| Jun 1999 | - | -$1.90M(+18.8%) | -$7.90M(+2.6%) |
| Mar 1999 | - | -$1.60M(-38.5%) | -$7.70M(+1.3%) |
| Dec 1998 | -$7.80M(+100.0%) | -$2.60M(+44.4%) | -$7.60M(+26.7%) |
| Sep 1998 | - | -$1.80M(+5.9%) | -$6.00M(+17.6%) |
| Jun 1998 | - | -$1.70M(+13.3%) | -$5.10M(+10.9%) |
| Mar 1998 | - | -$1.50M(+50.0%) | -$4.60M(+24.3%) |
| Dec 1997 | -$3.90M(+77.3%) | -$1.00M(+11.1%) | -$3.70M(+37.0%) |
| Sep 1997 | - | -$900.00K(-25.0%) | -$2.70M(+50.0%) |
| Jun 1997 | - | -$1.20M(+100.0%) | -$1.80M(+200.0%) |
| Mar 1997 | - | -$600.00K | -$600.00K |
| Dec 1996 | -$2.20M | - | - |
FAQ
- What is Sarepta Therapeutics annual operating income?
- What is the all time high annual operating profit for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual operating profit year-on-year change?
- What is Sarepta Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly operating profit year-on-year change?
- What is Sarepta Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Sarepta Therapeutics?
- What is Sarepta Therapeutics TTM operating profit year-on-year change?
What is Sarepta Therapeutics annual operating income?
The current annual operating profit of SRPT is $218.08M
What is the all time high annual operating profit for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual operating income is $218.08M
What is Sarepta Therapeutics annual operating profit year-on-year change?
Over the past year, SRPT annual operating income has changed by +$485.90M (+181.43%)
What is Sarepta Therapeutics quarterly operating income?
The current quarterly operating profit of SRPT is -$300.39M
What is the all time high quarterly operating profit for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly operating income is $161.68M
What is Sarepta Therapeutics quarterly operating profit year-on-year change?
Over the past year, SRPT quarterly operating income has changed by -$335.29M (-960.58%)
What is Sarepta Therapeutics TTM operating income?
The current TTM operating profit of SRPT is -$117.21M
What is the all time high TTM operating profit for Sarepta Therapeutics?
Sarepta Therapeutics all-time high TTM operating income is $218.08M
What is Sarepta Therapeutics TTM operating profit year-on-year change?
Over the past year, SRPT TTM operating income has changed by -$22.38M (-23.60%)